Lightnews — Scholar-powered news

The Society for Functional Precision Medicine @thesfpm.bsky.social · 18h

🚨Excited to announce the seminar by Kushtrim Kryeziu, PhD (Oslo University) on "Functional Precision Oncology for Metastatic Colorectal Cancer". Join us TODAY, at 12 PM EDT, open to everyone! Don't miss it and consider joining the SFPM

www.sfpm.io/seminars

Seminars | SFPM

The SFPM Seminar series is for those interested in the use of assaying technology to further biomarker discovery, drug R&D and personalized healthcare outcomes.

www.sfpm.io

1

Reposted by The Society for Functional Precision Medicine

Soragni:Lab @alice.soragnilab.com · 9d

What incredible news today. I feel so grateful to have worked closely with Tony over the years and to have witnessed firsthand his vision, energy, and commitment to advancing functional precision medicine. I cannot think of a steadier (and more needed) force at the NCI at this time /n

The Society for Functional Precision Medicine @thesfpm.bsky.social · 9d

We want to congratulate our President, Dr. Tony Letai, on his appointment as Director of the NCI. This announcement marks an historic moment for cancer research. Dr. Letai has been a tireless advocate and visionary leader for functional precision medicine 🧵

www.nih.gov/news-events/...

Secretary Kennedy Swears in Dr. Anthony Letai as Director of the National Cancer Institute

Dr. Letai will serve as NCI’s 18th director.

www.nih.gov

1 9 28

The Society for Functional Precision Medicine @thesfpm.bsky.social · 9d

Please join us in thanking him for his service to SfPM and congratulating him on this momentous new chapter. In light of this transition, new Board openings will be announced, with elections to follow. SfPM members will receive additional details in the coming weeks.

2

The Society for Functional Precision Medicine @thesfpm.bsky.social · 9d

His leadership has strengthened our community and accelerated progress toward a future where functional precision medicine improves outcomes for patients everywhere. We are inspired to see Dr. Letai bring his stabilizing, trailblazing force to the NCI at such a critical time for cancer research.

1 2

The Society for Functional Precision Medicine @thesfpm.bsky.social · 9d

Dr. Letai has helped advance our field with conviction, generosity, and transformative insight. While we are saddened to see him step away from his role at SfPM, we are profoundly grateful for his years of service and unwavering support of our mission.

1 1

The Society for Functional Precision Medicine @thesfpm.bsky.social · 9d

We want to congratulate our President, Dr. Tony Letai, on his appointment as Director of the NCI. This announcement marks an historic moment for cancer research. Dr. Letai has been a tireless advocate and visionary leader for functional precision medicine 🧵

www.nih.gov/news-events/...

Secretary Kennedy Swears in Dr. Anthony Letai as Director of the National Cancer Institute

Dr. Letai will serve as NCI’s 18th director.

www.nih.gov

1 4 9

The Society for Functional Precision Medicine @thesfpm.bsky.social · 21d

We were honored to host Jens M. Kelm, PhD (PreComb Therapeutics) for our September seminar.

Dr. Kelm shared insights on:
🎯 Dynamic Drug Response Profiling at Scale for Functional Precision Oncology
If you missed the live session, you can now watch it here: www.youtube.com/watch?v=hIkR...

www.youtube.com

The Society for Functional Precision Medicine @thesfpm.bsky.social · Sep 8

✨ Excited to announce a talk by Jens M. Kelm, PhD (Founder and CSO PreComb Therapeutics AG) on "Dynamic Drug Response Profiling at Scale for Functional Precision Oncology", Join us next Wednesday, September 10, 2025, at 12 PM EDT. Don't miss it!

www.sfpm.io/seminars

Seminars | SFPM

The SFPM Seminar series is for those interested in the use of assaying technology to further biomarker discovery, drug R&D and personalized healthcare outcomes.

www.sfpm.io

The Society for Functional Precision Medicine @thesfpm.bsky.social · Jun 10

Join us this Wednesday 06/11 @ 12:00 PM EST for our monthly SFPM seminar! Dr. Chris Steffi from CompagOs will discuss: "Pioneering Solutions to Understand, Diagnose and Treat Bone Conditions"

More info & link to join: www.sfpm.io/seminars

Seminars | SFPM

The SFPM Seminar series is for those interested in the use of assaying technology to further biomarker discovery, drug R&D and personalized healthcare outcomes.

www.sfpm.io

1 1

The Society for Functional Precision Medicine @thesfpm.bsky.social · Jun 3

Precision approaches to tackle acquired resistance to cancer, including model-based functional strategies:
www.nature.com/articles/s41...

Acquired resistance in cancer: towards targeted therapeutic strategies - Nature Reviews Cancer

Acquired therapeutic resistance is a key contributor to cancer treatment failure, requiring new approaches to address its complex mechanisms. In this Roadmap, Soragni, Knudsen and colleagues discuss t...

www.nature.com

3

Reposted by The Society for Functional Precision Medicine

Mike-ghoul Half-man @michaelhoffman.bsky.social · Mar 12

In panel discussion on regulatory and non-regulatory challenges to the wide adoption of precision diagnostics. Chair Tony Letai. #AACRprecmed25 🧪🧬🖥️

2

Reposted by The Society for Functional Precision Medicine

Mike-ghoul Half-man @michaelhoffman.bsky.social · Mar 12

Now: Peter Horak. #AACRprecmed25 🧪🧬🖥️

1 1 1

Reposted by The Society for Functional Precision Medicine

Mike-ghoul Half-man @michaelhoffman.bsky.social · Mar 12

Now: Keith Ligon. #AACRprecmed25 🧪🧬🖥️

1 1 1

The Society for Functional Precision Medicine @thesfpm.bsky.social · Mar 12

Two of our Board members, Dr. Letai and Dr. Ligon, are part of this #AACRPM25 panel focused on regulatory and non-regulatory challenges to the wide adoption of precision diagnostics

1 1

The Society for Functional Precision Medicine @thesfpm.bsky.social · Mar 12

Join us *today* Wednesday 03/12 @ 12:00 PM EST for our monthly SFPM seminar!
Dr. Perova from EMBL-EBI will discuss: "Leveraging CancerModels.Org: enhancing precision oncology through collaborative cancer model resources"

More info: www.sfpm.io/seminars

Seminars | SFPM

The SFPM Seminar series is for those interested in the use of assaying technology to further biomarker discovery, drug R&D and personalized healthcare outcomes.

www.sfpm.io

Reposted by The Society for Functional Precision Medicine

Mike-ghoul Half-man @michaelhoffman.bsky.social · Mar 11

Now: Keith Flaherty: Targets and therapeutics in need of functional insights to guide drug development in solid tumors #AACRprecmed25 🧪🧬🖥️

2 1 5

Reposted by The Society for Functional Precision Medicine

Mike-ghoul Half-man @michaelhoffman.bsky.social · Mar 11

Continued 2: KF: Genetic evidence points to multiple resistance pathways #AACRprecmed25 🧪🧬🖥️ https://aacrjournals.org/clincancerres/article/24/24/6195/15360/Landscape-of-EGFR-Dependent-and-Independent

1 2 3

Reposted by The Society for Functional Precision Medicine

Mike-ghoul Half-man @michaelhoffman.bsky.social · Mar 11

Now: Jeffrey Tyner: Functional omics for novel therapeutic combinations in myeloid malignancies #AACRprecmed25 🧪🧬🖥️

1 2 4

Reposted by The Society for Functional Precision Medicine

Mike-ghoul Half-man @michaelhoffman.bsky.social · Mar 11

Continued 2: JT: Experimental approach: primary cells -> overnight exposure -> CITE-seq: dynamic changes and cell persistence under therapeutic selective pressure. With @wondermixtape.bsky.social #AACRprecmed25 🧪🧬🖥️

1 2 3

Reposted by The Society for Functional Precision Medicine

Mike-ghoul Half-man @michaelhoffman.bsky.social · Mar 11

Now: Coleman Lindsley: Dyanmic assessment in leukemia. What is minimal residual disease and does it matter? #AACRprecmed25 🧪🧬🖥️

1 2 6

Reposted by The Society for Functional Precision Medicine

Mike-ghoul Half-man @michaelhoffman.bsky.social · Mar 11

Now: Sascha Dietrich: Ex vivo drug response profiling for response and outcome prediction in hematologic malignancies #AACRprecmed25 🧪🧬🖥️

1 1 1

Reposted by The Society for Functional Precision Medicine

Mike-ghoul Half-man @michaelhoffman.bsky.social · Mar 11

On my way to @theaacr.bsky.social special conference in cancer research: functional and genomic precision medicine in cancer. Who else will be there? @alice.soragnilab.com #AACRprecmed25 www.aacr.org/meeting/aacr...

AACR Special Conference in Cancer Research: Functional and Genomic Precision Medicine in Cancer: Different Perspectives, Common Goals

Overview for AACR Special Conference in Cancer Research: Functional and Genomic Precision Medicine in Cancer: Different Perspectives, Common Goals

www.aacr.org

2 4 10

Reposted by The Society for Functional Precision Medicine

Soragni:Lab @alice.soragnilab.com · Mar 11

This first AACR meeting on functional and genomic precision medicine has officially started! Dr. Mardis gave the introductory remarks followed by our first plenary speaker, Dr. Flaherty, who will focus on the collision of genomic and functional precision medicine #AACRPM25

Elaine Mardis giving introductory remarks

3 12

Reposted by The Society for Functional Precision Medicine

Joan Montero @joanmontero.bsky.social · Mar 11

Do not miss this great talk tomorrow at 5pm CET (12pm EDT): Zinaida Perova (EMBL) "Leveraging CancerModels.Org: Enhancing Precision Oncology Through Collaborative Cancer Model Resources". @thesfpm.bsky.social

www.sfpm.io/seminars

1 1

The Society for Functional Precision Medicine @thesfpm.bsky.social · Feb 12

Join us *today* Wednesday 02/12 @ 12:00 PM EST for our monthly SFPM seminar!

Dr. Andrew Satterlee from UNC will discuss overcoming systemic barriers to functional precision medicine using a versatile ex vivo model of patient brain tumors.

More info: www.sfpm.io/seminars

1